Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient
- Conditions
- to Predict an Unfavorable Evolution of Covid-19 at the Hospital Admission of Patients
- Registration Number
- NCT04412031
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
The project is a part of the "Protocol for a multicentre study of nosocomial SARS-CoV2 transmission: The NOSO-COR Project" registered in ClinicalTrials (NCT04290780).
In the current pandemic context, medical resources have often been exceeded. Developing, using artificial intelligence techniques, an algorithm capable of detecting patients at risk of acute respiratory distress following Sars-Cov2 infection could help physicians to optimize the treatment of patients and health decision-makers to optimize resources. Thus, the goal of this project is to create a prediction model using artificial intelligence to predict an unfavorable evolution of Covid-19 at the hospital admission of patients
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 802
- Participant must be 18 years or older at the time of signing the informed consent
- Volunteer patients, care givers and healthcare professionals in France and hospitals affiliated with the GABRIEL network. Demographic and clinical data will be collected using case-report forms designed especially for the purpose of the project.
- A nasopharyngeal swab will be collected and tested for SARS-CoV2 by RT-PCR.
- Admission to hospital
- Age lower than 18 years old
- Patients protected by the law
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Need of mechanical ventilation, transfer to an intensive care unit or death within 21 days of admission. within 21 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hôpital E Herriot - Hospices Civils de LYON
🇫🇷Lyon, France